Clinical Trial Detail

NCT ID NCT03117751
Title Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphocytic leukemia

lymphoblastic lymphoma

Therapies

Cyclophosphamide

Vincristine

Idarubicin

Blinatumomab

Doxorubicin

Clofarabine

Vorinostat

Ruxolitinib

Prednisone

Bortezomib

Etoposide

Dasatinib

Daunorubicin

Dexamethasone

Rituximab

Methotrexate

Cytarabine

Mercaptopurine

Pegaspargase

Age Groups: child adult

No variant requirements are available.